Ogilvy scores US account for Pfizer's pain franchise
NEW YORK: Ogilvy PR has walked away with the highly coveted Pfizer pain franchise account, which includes arthritis drugs Celebrex and Bextra, the pharmaceutical company said.
Sign in to continue
Need to activate your subscription?
Domain/Group Subscriptions
Click here >>
Individual Subscriptions
Click here >>
Need to activate your Subscription
Company Wide Subscriptions
Click here >>
UK Individual Subscribers
Click here >>